CalAmp has entered a strategic collaboration with Cryoport to develop a next generation condition monitoring system to further assure the security of global temperature controlled pharmaceutical shipments. Together with CalAmp, Cryoport is exploring an advanced supply chain visibility service that will monitor, in real-time, environmental readings for regenerative medicine product shipments using Bluetooth sensor technology.

This research and development collaboration aims to enhance the protection and preservation of critical life science shipments by combining the Cryoport Express Shippers and the Cryoportal Logistics Management Platform, with CalAmp’s SC iOn Tag Bluetooth sensor technology and SC iOn Command platform. If successful, it would allow Cryoport to offer an advanced logistics solution that would pro-actively manage supply chain visibility across multi-mode global shipping routes. 

“We are pleased with the relationship we are developing with CalAmp and the potential to provide advanced, next generation wireless, Bluetooth solutions that will track and report crucial information for life science shipments in ways that were heretofore not possible,” said Jerrell Shelton, chief executive officer of Cryoport. “We are entrusted with highly sensitive and valuable commodities, which require advanced technologies to provide safe and secure conditions at all times. Our Biopharma, Reproductive Medicine, and Animal Health markets require superior quality assurance and non-stop monitoring. The SaaS solutions we are working with CalAmp to develop should, if successful, enable us to add offerings that will significantly reduce the risks associated with the temperature-controlled transportation of commodities in our markets.” 

“We know how important it is to have access to accurate and sophisticated technology when handling temperature-sensitive commodities,” said Jeff Newman, vice president of supply chain visibility solutions at CalAmp. “For supply chain and cold chain suppliers that are entrusted with these products, having real-time insight not only saves money, it also has the ability to save lives and advance the development of groundbreaking new cellular therapies. We are honored to have started this relationship with Cryoport.”